Sebastian Katz | Chief Strategy Officer
SteinCares

Sebastian Katz brings over 20 years of experience in the global pharmaceutical industry across General Management, Finance, Corporate Strategy, and Business Development.
As Chief Strategy Officer at SteinCares, Sebastian leads the global business development team and drives the company's expansion strategy across Latin America. Under his leadership, SteinCares has built a biosimilar portfolio of seven approved products and a contracted pipeline of 12+ molecules, supported by exclusive licensing agreements with eight leading global biosimilar manufacturers — within a broader specialty care portfolio of 20+ strategic partnerships across the region.
Sebastian holds an Executive MBA from IAE Business School and has completed specialized training in Pharmaceutical Marketing and Management at the Kellogg School of Management.
With deep expertise in specialty care and a firsthand view of Latin America's evolving healthcare landscape, Sebastian offers a grounded, strategic perspective on the forces shaping the industry's future in the region. Key areas of expertise include:

• Expansion and Growth Strategies in Emerging Pharmaceutical Markets: SteinCares' Model in Latin America.
• Building a High-Value Pipeline in Latin America: In-Licensing, Strategic Partnerships, and Business Development in Specialty Care.
• The Role of Biosimilars and Complex Generics in Expanding Access to Specialty Therapies: Lessons Learned and the Road Ahead.
• Navigating the Regulatory and Market Access Landscape in Latin America: Challenges and Opportunities for Pharmaceutical Innovation.
• Building Sustainable Business Models in Specialty Care: How SteinCares Drives Growth While Improving Patient Outcomes.